Cargando…

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate

BACKGROUND: Due to the lack of protective immunity of humans towards the newly emerged SARS-CoV-2, this virus has caused a massive pandemic across the world resulting in hundreds of thousands of deaths. Thus, a vaccine is urgently needed to contain the spread of the virus. METHODS: Here, we describe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Weina, Leist, Sarah R., McCroskery, Stephen, Liu, Yonghong, Slamanig, Stefan, Oliva, Justine, Amanat, Fatima, Schäfer, Alexandra, Dinnon, Kenneth H., García-Sastre, Adolfo, Krammer, Florian, Baric, Ralph S., Palese, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679520/ https://www.ncbi.nlm.nih.gov/pubmed/33232870 http://dx.doi.org/10.1016/j.ebiom.2020.103132

Ejemplares similares

A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
por: Sun, Weina, et al.
Publicado: (2020)

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
por: Sun, Weina, et al.
Publicado: (2021)

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice
por: González-Domínguez, Irene, et al.
Publicado: (2022)

Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice
por: González-Domínguez, Irene, et al.
Publicado: (2022)

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
por: Tcheou, Johnstone, et al.
Publicado: (2021)

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
por: Pitisuttithum, Punnee, et al.
Publicado: (2022)

MECHANISM OF PRODUCTION OF PULMONARY LESIONS IN MICE BY NEWCASTLE DISEASE VIRUS (NDV)
por: Ginsberg, Harold S.
Publicado: (1951)

Development of a Recombinant Thermostable Newcastle Disease Virus (NDV) Vaccine Express Infectious Bronchitis Virus (IBV) Multiple Epitopes for Protecting against IBV and NDV Challenges
por: Tan, Lei, et al.
Publicado: (2020)

A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2018)

Author Correction: A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2020)

Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein
por: Chumbe, Ana, et al.
Publicado: (2017)

Protection against Different Genotypes of Newcastle Disease Viruses (NDV) Afforded by an Adenovirus-Vectored Fusion Protein and Live NDV Vaccines in Chickens
por: Ferreira, Helena L., et al.
Publicado: (2021)

Recombinant Newcastle disease virus (NDV) expressing Duck Tembusu virus (DTMUV) pre-membrane and envelope proteins protects ducks against DTMUV and NDV challenge
por: Sun, Minhua, et al.
Publicado: (2018)

Adaptation of Newcastle Disease Virus (NDV) in Feral Birds and their Potential Role in Interspecies Transmission
por: Rahman, Aziz-ul-, et al.
Publicado: (2018)

Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV
por: Roohani, Kiarash, et al.
Publicado: (2015)

Recombinant Newcastle Disease Virus (NDV) Expressing Sigma C Protein of Avian Reovirus (ARV) Protects against Both ARV and NDV in Chickens
por: Saikia, Deep Prakash, et al.
Publicado: (2019)

Antiviral interferons induced by Newcastle disease virus (NDV) drive a tumor-selective apoptosis
por: Ginting, Teridah Ernala, et al.
Publicado: (2019)

Recombinant-attenuated Salmonella Pullorum strain expressing the hemagglutinin-neuraminidase protein of Newcastle disease virus (NDV) protects chickens against NDV and Salmonella Pullorum challenge
por: Ding, Ke, et al.
Publicado: (2018)

Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
por: García-Romero, Noemi, et al.
Publicado: (2020)

Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge
por: Yang, Xin, et al.
Publicado: (2016)

Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice
por: Liu, Yonghong, et al.
Publicado: (2021)

Chimeric Newcastle Disease Virus Protects Chickens against Avian Influenza in the Presence of Maternally Derived NDV Immunity
por: Steglich, Constanze, et al.
Publicado: (2013)

Mucosal delivery of RNA vaccines by Newcastle disease virus vectors
por: García-Sastre, Adolfo
Publicado: (2022)

In silico prediction of B and T cell epitopes based on NDV fusion protein for vaccine development against Newcastle disease virus
por: Hosseini, Seyedeh Somayeh, et al.
Publicado: (2021)

Thymic transcriptome analysis after Newcastle disease virus inoculation in chickens and the influence of host small RNAs on NDV replication
por: Guo, Liangxing, et al.
Publicado: (2021)

AN ELECTRON MICROSCOPIC STUDY OF INCOMPLETE VIRUS FORMATION : INFECTION OF EHRLICH ASCITES TUMOR CELLS WITH "CHICK EMBRYO-ADAPTED" NEWCASTLE DISEASE VIRUS (NDV)
por: Adams, W. Robert, et al.
Publicado: (1957)

Package of NDV-Pseudotyped HIV-Luc Virus and Its Application in the Neutralization Assay for NDV Infection
por: Wang, Bin, et al.
Publicado: (2014)

Rapid Generation of a Recombinant Genotype VIII Newcastle Disease Virus (NDV) Using Full-Length Synthetic cDNA
por: Murulitharan, Kavitha, et al.
Publicado: (2021)

Evaluation of inactivated avian influenza virus and Newcastle disease virus bivalent vaccination program against newly circulated H5N8 and NDV strains
por: Azab, Ahmed A., et al.
Publicado: (2023)

Single-Dose Vaccination of Recombinant Chimeric Newcastle Disease Virus (NDV) LaSota Vaccine Strain Expressing Infectious Bursal Disease Virus (IBDV) VP2 Gene Provides Full Protection against Genotype VII NDV and IBDV Challenge
por: Qiao, Qilong, et al.
Publicado: (2021)

RECEPTOR DESTRUCTION BY VIRUSES OF THE MUMPS-NDV-INFLUENZA GROUP
por: Hirst, George K.
Publicado: (1950)

Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy
por: Vigil, Adam, et al.
Publicado: (2008)

Characterization of a Recombinant Thermostable Newcastle Disease Virus (NDV) Expressing Glycoprotein gB of Infectious Laryngotracheitis Virus (ILTV) Protects Chickens against ILTV Challenge
por: Zeng, Zhe, et al.
Publicado: (2023)

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam
por: Duc Dang, Anh, et al.
Publicado: (2022)

A Booster with a Genotype-Matched Inactivated Newcastle Disease Virus (NDV) Vaccine Candidate Provides Better Protection against a Virulent Genotype XIII.2 Virus
por: Hossain, Ismail, et al.
Publicado: (2023)

Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect
por: Pan, Ziye, et al.
Publicado: (2016)

Correction: Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect
por: Pan, Ziye, et al.
Publicado: (2017)

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations
por: Rajendran, Madhusudan, et al.
Publicado: (2018)

Spike Gene Determinants of Mouse Hepatitis Virus Host Range Expansion
por: McRoy, Willie C., et al.
Publicado: (2006)

Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs
por: Lara-Puente, Jesús Horacio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sm8vc9gqga7sep90ps5h69m2ve